Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Metastatic Pancreatic Cancer

Clinical Trials

    • Cancer(5)
  • Pancreatic Cancer

    A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

    • Pancreatic Cancer

      The Cancer of the Pancreas Screening-5 (CAPS5) Study

      • Ages18 years and older
      • GenderBoth
    • Pancreatic Cancer

      Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma

      • Pancreatic Cancer

        Phase II Randomized, Prospective Trial of Lutetium Lu 177 Dotatate PRRT Versus Capecitabine and Temozolomide in Well-Differentiated Pancreatic Neuroendocrine Tumors

        • Pancreatic Cancer

          A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients With Resected Pancreatic Ductal Adenocarcinoma

          • About Us
          • Contact Us
          • Donate
          • Referring Doctors
          • Clinical Keywords

          333 Cedar St.

          New Haven, CT 06510

          • Yale School of Medicine
          • Yale University
          • Terms & Privacy Policies
          • Accessibility at YSM
          • Patient Rights
          • HIPAA at Yale
          • Non-discrimination Statement
          Copyright 2025 Yale Medicine